Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 28, Issue 4, 2010, Pages 620-627

  Chrischilles, Elizabeth A ^a   Pendergast, Jane F ^a   Kahn, Katherine L ^a   Wallace, Robert B ^a   Moga, Daniela C ^a   Harrington, David P ^a   Kiefe, Catarina I ^a   Weeks, Jane C ^a   West, Dee W ^a   Zafar, S Yousuf ^a   Fletcher, Robert H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PLATINUM; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMMUNITY CARE; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ELDERLY CARE; FEMALE; FEVER; FRACTURE; GASTROINTESTINAL HEMORRHAGE; GROUPS BY AGE; HEART ARREST; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NEUTROPENIA; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPSIS; STROKE; SUPERIOR CAVA VEIN SYNDROME; ADENOCARCINOMA; COHORT ANALYSIS; FOLLOW UP; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77449086119     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.8485     Document Type: Article

References (27)

1. Surveillance Epidemiology and End Results. http://www.seer.cancer.gov/ faststats/
2. Non-Small-Cell Lung Cancer Collaborative Group. Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899-909, 1995
3. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98, 2002 (Pubitemid 34438899)
4. Treat J, Belani CP, Edelman MJ, et al: A randomized phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small-cell lung cancer (NSCLC): Update of the alpha oncology trial (A1-99002L). J Clin Oncol 23:627s, 2005 (abstr LBA7025)
5. Gridelli C: The ELVIS trial: A phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small-cell lung cancer: Elderly Lung Cancer Vinorelbine Italian Study. Oncologist 6:4-7, 2001 (suppl 1) (Pubitemid 32155180)
6. Gridelli C, Perrone F, Gallo C, et al: Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small-cell lung cancer: A two-stage phase II study. Eur J Cancer 33:392-397, 1997 (Pubitemid 27168064)
7. Hensing TA, Peterman AH, Schell MJ, et al: The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV non-small-cell lung carcinoma treated with carboplatin and paclitaxel. Cancer 98:779-788, 2003
8. Owonikoko TK, Ragin CC, Belani CP, et al: Lung cancer in elderly patients: An analysis of the Surveillance, Epidemiology, and End Results Database. J Clin Oncol 25:5570-5577, 2007
9. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age older in cancer-treatment trials. N Engl J Med 341: 2061-2067, 1999 (Pubitemid 30035956)
10. Jennens RR, Giles GG, Fox RM: Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials. Intern Med J 36:216-220, 2006
11. Gridelli C, Shepherd FA: Chemotherapy for elderly patients with non-small cell lung cancer: A review of the evidence. Chest 128:947-957, 2005 (Pubitemid 41140531)
12. Hotta K, Ueoka H, Kiura K, et al: An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small-cell lung cancer. Lung Cancer 46:61-76, 2004 (Pubitemid 39201385)
13. Potosky AL, Saxman S, Wallace RB, et al: Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 22:3261-3268, 2004 (Pubitemid 41103681)
14. Ayanian JZ, Chrischilles EA, Wallace RB, et al: Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22:2992-2996, 2004
15. Malin JL, Ko C, Ayanian JZ, et al: Understanding cancer patients' experience and outcome: Development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 14:837-848, 2006 (Pubitemid 44063448)
16. Piccirillo JF, Costas I, Claybour Pet al: The measurement of comorbidity by cancer registries. J Registry Manage 30:8-14, 2003
17. Graubard B, Korn E: Predictive margins with survey data. Biometrics 55:652-659, 1999
18. Rubin D: Multiple Imputation for Nonresponse in Surveys. New York, NY, John Wiley & Sons, 1987
19. Earle CC, Tsai JS, Gelber RD, et al: Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis. J Clin Oncol 19:1064-1070, 2001
20. Smith TJ, Penberthy L, Desch CE, et al: Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer 13:235-252, 1995 (Pubitemid 26022990)
21. Ramsey SD, Howlader N, Etzioni RD, et al: Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: Evidence from Surveillance, Epidemiology and End Results-Medicare. J Clin Oncol 22:4971-4978, 2004 (Pubitemid 46638623)
22. Deppermann KM: Influence of age and co-morbidities on the chemotherapeutic management of lung cancer. Lung Cancer 33:S115-S120, 2001 (suppl 1)
23. Janssen-Heijnen MLG, Schipper RM, Razenberg PPA, et al: Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based study. Lung Cancer 21:105-113, 1998
24. Extermann M, Overcash J, Lyman GH, et al: Comorbid condition and functional status are independent in older cancer patients. J Clin Oncol 16: 1582-1587, 1998 (Pubitemid 28175784)
25. Hillner BE, McDonald MK, Desch CE, et al: A comparison of patterns of care of non-small-cell lung carcinoma patients in a younger and Medigap commercially insured cohort. Cancer 83:1930-1937, 1998
26. Earle CC, Venditti LN, Neumann PJ, et al: Who gets chemotherapy for metastatic lung cancer? Chest 117:1239-1246, 2000
27. Nafees B, Stafford M, Gavriel S, et al. Health state utilities for non-small-cell lung cancer. Health Qual Life Outcomes 6:84, 2008